2016-2020 EU5 Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

March 2016 | 495 pages | ID: 2D78C7F577FEN
Venture Planning Group

Abstracts

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new five-country study from VPGMarketResearch contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Contents

INTRODUCTION

Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
  1. Overview
  2. Major Cancer Types
  3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
  1. Overview
  2. Nucleic Acid Amplification
  3. Chromosome Imaging
  4. Genomics Technologies
  5. Proteomics Technologies
  6. Current Pharmacogenomic Testing
  7. Major Diseases
I. Forensic Molecular Diagnostics Testing
  1. Overview
  2. Multilocus and Single Locus Probes
  3. The FBI
  4. DNA Profile Data Banks
  5. Judicial Implementation
  6. Major Crime Categories
  7. Factors Contributing to the DNA Probe
Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products

ALTERNATIVE MARKET PENETRATION STRATEGIES

Potential Market Entry Barriers And Risks

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Appendixes

List Of Tables

LIST OF TABLES

Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests
For Genetic Diseases
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment
France, Molecular Diagnostic Test Volume Forecast By Major Application
France, Molecular Diagnostics Market Forecast By Major Application
France, Molecular Diagnostics Market By Major Supplier
Germany, Laboratories Performing
DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Molecular Diagnostic Test Volume Forecast By Major Application
Germany, Molecular Diagnostic Market Forecast By Major Application
Germany, Molecular Diagnostics
Market by Major Supplier
Italy, Laboratories Performing
DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment
Italy, Molecular Diagnostic Test Volume Forecast By Major Application
Italy, Molecular Diagnostic Market Forecast By Major Application
Italy, Molecular Diagnostics Market By Major Supplier
Spain, Laboratories Performing
DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential
Laboratory Universe by Market Segment
Spain, Molecular Diagnostic Test Volume Forecast By Major Application
Spain, Molecular Diagnostic Market Forecast By Major Application
Spain, Molecular Diagnostics Market By Major Supplier
U.K., Laboratories Performing
DNA Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment
U.K., Molecular Diagnostic Test Volume Forecast By Major Application
U.K., Molecular Diagnostic Market Forecast By Major Application
U.K., Molecular Diagnostics Market by Major Supplier